These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10419703)

  • 1. Telomerase activity in phyllodes tumours.
    Mokbel K; Ghilchik M; Parris CN; Newbold RF
    Eur J Surg Oncol; 1999 Aug; 25(4):352-5. PubMed ID: 10419703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
    He GP; Shui QL; Huang Y; Zhang SZ; Yu H
    Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
    Hiyama E; Saeki T; Hiyama K; Takashima S; Shay JW; Matsuura Y; Yokoyama T
    Cancer; 2000 Aug; 90(4):235-8. PubMed ID: 10966564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A patient with pulmonary metastasis of phyllodes tumour of the breast].
    Solberg OG; Blom GP; Stavem K
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2956-7. PubMed ID: 16299881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomerase activity in breast carcinoma].
    Yang W; Xu L; Zhang T
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):278-80. PubMed ID: 11776815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and Bcl-2 expression in human breast cancer.
    Elkak AE; Kirkpatrick K; Mears L; Wells C; Ghilchik M; Newbold R; Mokbel K
    Eur J Surg Oncol; 2002 Feb; 28(1):14-8. PubMed ID: 11869007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and its inhibition in benign and malignant breast lesions.
    Sugino T; Yoshida K; Bolodeoku J; Tarin D; Goodison S
    J Pathol; 1997 Sep; 183(1):57-61. PubMed ID: 9370948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in neuroendocrine tumors.
    Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
    Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in head and neck cancer.
    Kunická Z; Mucha I; Fajkus J
    Anticancer Res; 2008; 28(5B):3125-9. PubMed ID: 19031968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
    Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
    Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
    Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
    J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrosarcoma is not characterized by detectable telomerase activity.
    Bovée JV; van Den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyllodes tumor of the breast.
    Reinfuss M; Mitus J; Stelmach A
    Strahlenther Onkol; 1995 Jan; 171(1):5-11. PubMed ID: 7839306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in prognostic histopathologic features of melanoma.
    Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
    J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllodes tumours of the breast--a retrospective study from 1982-2000 of 50 cases in Portsmouth.
    Sotheran W; Domjan J; Jeffrey M; Wise MH; Perry PM
    Ann R Coll Surg Engl; 2005 Sep; 87(5):339-44. PubMed ID: 16176692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
    Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomas and malignant phyllodes tumours of the breast--a retrospective study.
    Confavreux C; Lurkin A; Mitton N; Blondet R; Saba C; Ranchère D; Sunyach MP; Thiesse P; Biron P; Blay JY; Ray-Coquard I
    Eur J Cancer; 2006 Nov; 42(16):2715-21. PubMed ID: 17023158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.